DaVita

DaVita is one of the largest providers of kidney dialysis services in the United States, operating a nationwide network of outpatient centres that treat patients with chronic kidney failure. Its business is driven by recurring treatment volumes and long-standing relationships with payers, giving it steady demand rooted in an ongoing medical need. DaVita pays no dividend, choosing instead to return capital almost entirely through share buybacks, which have significantly reduced its share count over time. Income investors will find nothing here, and the low score reflects the lack of any distribution. The profile is one of a steady operator that channels its cash into repurchases rather than dividends.